Approval of Marketing Plan and Materials Sample Clauses

Approval of Marketing Plan and Materials. The Contractor shall submit to SCDHHS or its designee all marketing plans and written materials directed at Medicaid eligibles or potential eligibles for approval. These materials include, but are not limited to, materials produced for marketing, member education, evidence of coverage, and grievance procedures. Marketing materials include all types of media including brochures, leaflets, newspapers, magazines, radio, television, billboard and yellow page advertisements directed at Medicaid eligibles or potential eligibles. They also include internet-based materials.
AutoNDA by SimpleDocs
Approval of Marketing Plan and Materials. The Contractor shall submit to SCDHHS or its designee all marketing plans and written materials directed at SCHIP eligibles or potential eligibles for approval. These materials include, but are not limited to: materials produced for marketing, member education, evidence of coverage, member handbook and grievance procedures. Marketing materials include all types of media including brochures, leaflets, newspapers, magazines, radio, television, billboard and yellow page advertisements directed at eligibles or potential eligibles. They also include internet-based materials. 8 POST ENROLLMENT PROCESS The post enrollment process for the SCHIP MCO program shall be as follows:
Approval of Marketing Plan and Materials. The CCN shall submit to DHH or its designee all marketing plans and written materials directed at Medicaid eligibles, current CCN members or potential
Approval of Marketing Plan and Materials. The Contractor shall submit to SCDHHS or its designee all marketing plans and written materials directed at SCHIP eligibles or potential eligibles for prior approval. These materials include, but are not limited to: materials produced for marketing, member education, evidence of coverage, member handbook and grievance procedures. Marketing materials include all types of media such as brochures, leaflets, newspapers, and magazines, and radio, television, billboard and yellow page advertisements directed at eligibles or potential eligibles. Marketing materials also include internet-based materials and methods of delivery such as Tweeter, etc . 8 POST ENROLLMENT PROCESS
Approval of Marketing Plan and Materials. The Contractor shall submit to SCDHHS or its designee for approval all marketing plans and written materials directed at Medicaid eligibles or potential eligibles. These materials include, but are not limited to, materials produced for marketing, member education, evidence of coverage, and grievance procedures. Marketing materials include all types of media including brochures, leaflets, newspapers, magazines, radio, television, billboard and yellow page advertisements directed at Medicaid eligibles or potential eligibles. For each new Contract period (or extension of existing Contract), the Contractor shall submit no later than sixty (60) calendar days prior to Contract renewal, and for any changes during the contract period no later than sixty (60) calendar days prior to implementation, its marketing plan and materials, including, but not limited to, enrollment/education materials, brochures, fact sheets, posters and lectures to SCDHHS for written approval. The SCDHHS or its designee shall review marketing materials and determine whether to grant approval. In the event SCDHHS or its designee does not respond within thirty (30) working days after the Contractor submits such materials for approval, the Contractor shall notify SCDHHS or its designee for further action.
Approval of Marketing Plan and Materials. Spalding and Licensee will develop mutually acceptable business and marketing plans which address the subjects set forth in Exhibit 9.2, including, types of media for Licensee's advertising and merchandising programs, proposed advertising, promotional, marketing, distribution and sales strategies and targets for the Licensed Products (the "Business and Marketing Plans"). The Marketing Plan shall assign responsibility for completing the actions set forth in the Marketing Plan. Spalding shall have absolute control over the creation and production of advertising, promotional, merchandising and other marketing materials for which Spalding is responsible. Spalding shall approve in advance all advertising, promotional, merchandising and other marketing materials for which Licensee is responsible, including without limitation: (i) all containers, packaging, labels, tags and the like; (ii) all advertising, promotional, merchandising and other marketing materials; (iii) all stationery, business cards and invoices; and (iv) all other transaction documents and business materials. Licensee shall submit such materials in their proposed final form to Spalding at least thirty (30) business days before the proposed publication or release of such materials.
Approval of Marketing Plan and Materials. The Contractor shall submit to the Department, or its designee, all marketing plans and written materials directed at Medicaid Eligible or potential Eligible for prior approval. These materials include but are not limited to materials produced for marketing, Medicaid MCO Member education, evidence of coverage, Medicaid MCO Member handbook and grievance procedures. Marketing materials include all types of media such as brochures, leaflets, newspapers, and magazines, and radio, television, billboard and yellow page advertisements directed at Medicaid eligible or potential eligible. Marketing materials also include any electronic mail and internet-based materials. The post enrollment process for the Medicaid MCO Program shall be as follows:
AutoNDA by SimpleDocs
Approval of Marketing Plan and Materials. The Contractor shall submit to SCDHHS or its designee all marketing plans and written materials directed at Medicaid eligibles or potential eligibles for prior approval. These materials include, but are not limited to, materials produced for marketing, member education, evidence of coverage, and grievance procedures. Marketing materials such as all types of media including brochures, leaflets, newspapers and magazines, and radio, television, billboard and yellow page advertisements directed at Medicaid eligibles or potential eligibles. Marketing materials also include internet-based materials. 8 POST ENROLLMENT PROCESS The post enrollment process for the Medicaid MHN program shall be as follows:

Related to Approval of Marketing Plan and Materials

  • Promotional Materials In the event that the Fund or the Adviser makes available any promotional materials related to the Securities or the transactions contemplated hereby intended for use only by registered broker-dealers and registered representatives thereof by means of an Internet web site or similar electronic means, the Adviser will install and maintain, or will cause to be installed and maintained, pre-qualification and password-protection or similar procedures which are reasonably designed to effectively prohibit access to such promotional materials by persons other than registered broker-dealers and registered representatives thereof.

  • Commercialization Reports Throughout the term of this Agreement and during the Sell-Off Period, and within thirty (30) days of December 31st of each year, Company will deliver to University written reports of Company’s and Sublicensees’ efforts and plans to develop and commercialize the innovations covered by the Licensed Rights and to make and sell Licensed Products. Company will have no obligation to prepare commercialization reports in years where (a) Company delivers to University a written Sales Report with active sales, and (b) Company has fulfilled all Performance Milestones. In relation to each of the Performance Milestones each commercialization report will include sufficient information to demonstrate achievement of those Performance Milestones and will set out timeframes and plans for achieving those Performance Milestones which have not yet been met.

  • Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.

  • Regulatory Materials (a) On a Program-by-Program basis, commencing on the Effective Date until the Regulatory Transfer Date, Prothena shall have the right, in consultation with Celgene, to prepare, file and maintain all Regulatory Materials (including any Regulatory Approvals) necessary for the Development and Manufacture of any Collaboration Candidates and Collaboration Products for such Program (collectively, the “Program Regulatory Materials”), and to interact with Regulatory Authorities in connection with the Development and Manufacture of any Collaboration Candidates and Collaboration Products for such Program. Prothena will provide Celgene with a reasonable opportunity to comment substantively on all material Regulatory Materials prior to filing or taking material action, and will reasonably and in good faith consider any comments and actions recommended by Celgene, including with respect to filing strategy. In addition, Prothena will allow Celgene or its representative to attend any and all meetings with Regulatory Authorities to the extent such attendance is not prohibited or limited by such Regulatory Authority. (b) If Celgene exercises its Phase 1 Portion Participation Right for a given Program, then immediately after such exercise, Prothena shall initiate the transfer of all Program Regulatory Materials, including for clarity any IND for the relevant Collaboration Candidates and/or Collaboration Products that are the subject of such Program to Celgene. The date on which such Program Regulatory Materials are transferred to Celgene shall be the “Regulatory Transfer Date” for such Program. Thereafter, Celgene shall have the right, in consultation with Prothena, to prepare, file, and maintain such Program Regulatory Materials, and to interact with Regulatory Authorities in connection with the Development and, as applicable, Manufacture of such Collaboration Candidates and Collaboration Products for such Program in accordance with the terms and conditions of Section 2.5. Additionally, with respect to any Phase 1 Clinical Trial conducted by Celgene pursuant to Section 2.5, Celgene will provide Prothena with a reasonable opportunity to comment substantively on all material Program Regulatory Materials prior to filing or taking material action, and will reasonably and in good faith consider any comments and actions recommended by Prothena, including with respect to filing strategy. In addition, with respect to any Phase 1 Clinical Trial conducted by Celgene pursuant to Section 2.5, Celgene will allow Prothena or its representative to attend any and all meetings with Regulatory Authorities to the extent such attendance is not prohibited or limited by such Regulatory Authority. For clarity, if the Regulatory Transfer Date does not occur prior to the expiration of the Option Term for such Program, Section 2.6.1(a) (and not this Section 2.6.1(b)) shall apply.

  • Advertising and Promotional Materials The Purchaser acknowledges and agrees that the Vendor shall have the right to use drawings, photographs, videos or other depictions of the interior and/or exterior of the Dwelling and/or the Subdivision or any components or features thereof in any promotional or advertising materials without notice to or consent from the Purchaser being required in any manner whatsoever.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Marketing Materials (a) During the term of this Agreement, the Sub-Adviser agrees to furnish the Manager at its principal office for prior review and approval by the Manager all written and/or printed materials, including but not limited to, PowerPointÒ or slide presentations, news releases, advertisements, brochures, fact sheets and other promotional, informational or marketing materials (the “Marketing Materials”) for internal use or public dissemination, that are produced or are for use or reference by the Sub-Adviser, its affiliates or other designees, broker-dealers or the public in connection with the Series, and Sub-Adviser shall not use any such materials if the Manager reasonably objects in writing within five business days (or such other period as may be mutually agreed) after receipt thereof. Marketing Materials may be furnished to the Manager by first class or overnight mail, facsimile transmission equipment, electronic delivery or hand delivery. (b) During the term of this Agreement, the Manager agrees to furnish the Sub-Adviser at its principal office all prospectuses, proxy statements, reports to shareholders, or Marketing Materials prepared for distribution to shareholders of each Series, or the public that refer to the Sub-Adviser in any way, prior to the use thereof, and the Manager shall not use any such materials if the Sub-Adviser reasonably objects in writing within five business days (or such other period as may be mutually agreed) after receipt thereof. The Sub-Adviser’s right to object to such materials is limited to the portions of such materials that expressly relate to the Sub-Adviser, its services and its clients. The Manager agrees to use its reasonable best efforts to ensure that materials prepared by its employees or agents or its affiliates that refer to the Sub-Adviser or its clients in any way are consistent with those materials previously approved by the Sub-Adviser as referenced in the first sentence of this paragraph. Marketing Materials may be furnished to the Sub-Adviser by first class or overnight mail, facsimile transmission equipment, electronic delivery or hand delivery.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Promotional Material In the event that the Fund or the Investment Adviser makes available any promotional materials related to the Securities or the transactions contemplated hereby intended for use only by registered broker-dealers and registered representatives thereof by means of an Internet web site or similar electronic means, the Investment Adviser will install and maintain or will cause to be installed and maintained, pre-qualification and password-protection or similar procedures which are reasonably designed to effectively prohibit access to such promotional materials by persons other than registered broker-dealers and registered representatives thereof.

  • Marketing Plan The MCOP shall submit an annual marketing plan to ODM including all planned activities for promoting membership in or increasing awareness of the MCOP. The marketing plan submission shall include an attestation by the MCOP that the plan is accurate and is not intended to mislead, confuse, or defraud the eligible individuals or ODM.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!